HMedical ResearchEIN: 460886344· Ruling Year: 2014

Transcelerate Biopharma Inc

West Conshohocken, Pennsylvania

BHealth Score
58B

Financial Health Score

9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.

Above Average

How This Organization Compares

Compared to 5 peers in Medical Research with $10M-$100M revenue

Working Capital Ratio (net assets ÷ expenses)

This Org0.36×
Peer Median3.10×
💰
$34.2M
Total Revenue
📊
$32.5M
Total Expenses
🏦
$11.6M
Net Assets
📋
$36.5M
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+1.7%
Year-over-year change (2022 → 2023)
Net Margin
+4.8%
Revenue minus expenses as % of revenue
Working Capital Ratio
0.36
Net assets divided by total expenses
Liabilities-to-Assets
75.9%
Total liabilities as % of total assets

Filing History

12 filings on record
YearRevenueExpensesAssets
2023$34,168,8122%$32,521,1495%$48,107,6621%
2022$33,600,3028%$34,262,3723%$48,482,6604%
2021$31,090,6603%$33,180,34118%$50,373,3842%
2020$31,974,89414%$28,107,9655%$49,374,4108%
2019$27,979,34511%$26,700,07214%$45,613,19918%
2018$25,318,4453%$30,891,0376%$38,632,75012%
2017$26,172,58027%$29,275,31323%$43,979,8452%
2016$20,679,18419%$23,733,70446%$44,721,8133%
2015$25,465,26467%$16,269,49638%$43,370,07424%
2014$15,293,38812%$11,780,32373%$34,898,547285%
2013$13,643,765141%$6,823,30324%$9,075,30055%
2012$5,672,849$5,494,217$5,857,436

Frequently Asked Questions

What does Transcelerate Biopharma Inc do?

Transcelerate Biopharma Inc is a medical research nonprofit organization based in Pennsylvania. It is classified under NTEE code H99 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Transcelerate Biopharma Inc financially healthy?

Based on our 9-metric Financial Health Score model, Transcelerate Biopharma Inc has a score of 58/100 (Grade: B). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.

How much revenue does Transcelerate Biopharma Inc generate?

Transcelerate Biopharma Inc reports $38.6M in annual revenue and holds $55.3M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in Pennsylvania.